Yuva Biosciences
Birmingham, US · Founded 2019 · Delaware corporation · 5 known investors
Find your way into Yuva Biosciences
Sign up to find every way you can get introduced to Yuva Biosciences
- Your email: who you already know at Yuva Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Yuva Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Proprietary platform developing products to improve mitochondrial health.
Founders & leadership
GS
Greg SchmergelExecutive
Board
FE
Fred EhrsamBoard director
DB
Daniel BrowneBoard director
Investors · 5
TBD Angelslisted by TBD AngelsNew York
How we know: TBD Angels's portfolio page · longevity.technology · Not right? Tell us
Western Technology Investmentlisted by Western Technology InvestmentPortola Valley
How we know: Western Technology Investment's portfolio page · Not right? Tell us
VentureSouthreportedGreenville
How we know: funding news · longevity.technology · Not right? Tell us
Also in the syndicate · 2
Atma CapitalLongevity Tech Fund
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 of 2 rounds · 2023–2026
▶$1.1MraisedMar 2026 · 11 investors · OtherRule 506(b)
▶$1.1MraisedMar 2026 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Greg SchmergelExecutive Officer, Director
- Fred EhrsamDirector
- Daniel BrowneDirector
- Offering amount
- $3M
- Amount sold
- $1.1M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MofferedNov 2023 · OtherRule 506(b)
▶$4.5MofferedNov 2023 · Other
Rule 506(b)Officers, directors & promoters on the filing
- Greg SchmergelExecutive Officer, Director
- Offering amount
- $4.5M
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Yuva Biosciences do?
- Proprietary platform developing products to improve mitochondrial health.
- Who are Yuva Biosciences's investors?
- Yuva Biosciences's investors include TBD Angels, Western Technology Investment, VentureSouth.
- How much funding has Yuva Biosciences raised?
- Yuva Biosciences has disclosed $1.1M raised across 1 of its 2 known rounds.
- Where is Yuva Biosciences headquartered?
- Yuva Biosciences is headquartered in Birmingham, US.


